DRAinh-A250 is an orally active, reversible, specific and potent inhibitor of Cl-/anion exchanger SLC26A3 (downregulated in adenoma; DRA). DRAinh-A250 inhibits fluid absorption in mice closed colonic loops but not in jejunal loops. It is nontoxic in cell culture.
an orally active, reversible, specific and potent inhibitor of Cl-/anion exchanger SLC26A3
Storage Class
11 - Combustible Solids
wgk_germany
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Choose from one of the most recent versions:
Certificates of Analysis (COA)
Lot/Batch Number
It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.
SLC26A3 (downregulated in adenoma; DRA) is a Cl-/anion exchanger expressed in the luminal membrane of intestinal epithelial cells, where it facilitates electroneutral NaCl absorption. SLC26A3 loss of function in humans or mice causes chloride-losing diarrhea. Here, we identified slc26a3 inhibitors
Cellular and molecular gastroenterology and hepatology, 7(3), 641-653 (2019-01-20)
SLC26A3 (DRA) is an electroneutral Cl-/HCO3- exchanger that is present in the apical domain of multiple intestinal segments. An area that has continued to be poorly understood is related to DRA regulation in acute adenosine 3',5'-cyclic monophosphate (cAMP)-related diarrheas, in which DRA
Questions
Reviews
★★★★★ No rating value
Active Filters
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.